Johnson Fistel, PLLP is investigating potential claims on behalf of current, long-term shareholders of Inspire Medical Systems, Inc. (NYSE: INSP) against certain of their officers and directors for alleged breaches of fiduciary duty. Shareholders who have held shares continuously since prior to the dates listed below may have standing to seek corporate governance reforms focused on executive oversight, the return of funds to the Company, and a court-approved incentive award, at no cost to them.

If you have held Inspire Medical shares continuously since prior to August 6, 2024, you may have standing to seek corporate governance reforms focused on executive oversight at Inspire Medical.

Complaint Allegations
A previously filed securities class action complaint alleges that throughout the class period Defendants made false and misleading statements and failed to disclose material adverse facts regarding the launch of Inspire Medical’s Inspire V device. According to the complaint, demand for Inspire V was weaker than represented due to excess channel inventory and incomplete rollout preparation, including delays in training, contracting, onboarding, and Medicare billing capabilities. The complaint further alleges that these undisclosed issues adversely impacted demand and forced the Company to significantly reduce its earnings guidance, rendering Defendants’ prior public statements materially false or misleading.